ASLAN Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- ASLAN Pharmaceuticals's estimated annual revenue is currently $12.9M per year.
- ASLAN Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- ASLAN Pharmaceuticals has 64 Employees.
- ASLAN Pharmaceuticals grew their employee count by 5% last year.
ASLAN Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | General Counsel | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Finance Director | Reveal Email/Phone |
4 | Senior Clinical Trial Manager | Reveal Email/Phone |
5 | Senior Project Manager | Reveal Email/Phone |
6 | Sr. Manager, Clinical Development | Reveal Email/Phone |
7 | Immunology / Retinal Products Early Assets Team Leader | Reveal Email/Phone |
ASLAN Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1609.4M | 8007 | 7% | N/A | N/A |
#2 | $5.4M | 27 | N/A | N/A | N/A |
#3 | $3M | 15 | 0% | N/A | N/A |
#4 | $12.9M | 64 | 5% | N/A | N/A |
#5 | $14.7M | 73 | 14% | N/A | N/A |
What Is ASLAN Pharmaceuticals?
ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. Led by a senior management team with extensive experience in global development and commercialisation, ASLAN has a clinical portfolio comprised of a first-in-class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology. ASLAN's partners include Almirall, Array BioPharma, Bristol-Myers Squibb, and CSL.
keywords:N/A
N/A
Total Funding
64
Number of Employees
$12.9M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ASLAN Pharmaceuticals News
ASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to...
ASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to...
and SINGAPORE, March 28, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical...
Other Companies in Singapore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.7M | 64 | 5% | N/A |
#2 | $11.6M | 64 | 16% | N/A |
#3 | $8.2M | 65 | 14% | N/A |
#4 | $20.7M | 65 | 48% | N/A |
#5 | $9.4M | 65 | -22% | N/A |